$2.19
0.041.86%
At Close: -
$2.19
0.00130.06%
After Hours: 6:47 PM EDT
15 minutes delayed
Taysha Gene Therapies reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Taysha Gene Therapies using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-12 | $-0.09 | $-0.17 | 47.1 % |
Mar 2024 | 2024-05-14 | $-0.10 | $-0.11 | 9.09 % |
Dec 2023 | 2024-03-19 | $0.92 | $-0.11 | 936.4 % |
Sep 2023 | 2023-11-14 | $-0.93 | $-0.17 | -447.1 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-12 | $1.11M | $2.66M | -58.2 % |
Mar 2024 | 2024-05-14 | $3.41M | $2.56M | 33.2 % |
Dec 2023 | 2024-03-19 | $3.60M | $2.65M | 36.0 % |
Sep 2023 | 2023-11-14 | $4.75M | $1.40M | 239.0 % |
Taysha Gene Therapies (TSHA) is scheduled to report earnings on November 12, 2024. The last reported earnings were for reported on August 12, 2024 for Q2.
The Actual EPS was $-0.09, which beat the estimate of $-0.17.
The Actual Revenue was $1.1M, which missed the estimate of $2.7M.
Browse earnings estimates, EPS, and revenue on all stocks.